Search clinical trials for: FDG-PET scanning

Total 8624 results

University of British Columbia
British Columbia Cancer Agency

Unknown

11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues

Primary Hyperparathyroidism

Canada
Washington University School of Medicine

Terminated

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Cervical Cancer | Uterine Cervical Neoplasms | Uterine Cervical Cancer

United States
Marco Picardi
Federico II University

Unknown

Prospective Comparison Between FDG-PET/MR and FDG-PET/CT in Classical Hodgkin Lymphoma and DLBC Non-Hodgkin Lymphoma

Classical Hodgkin Lymphoma | Diffuse Large B-cell-lymphoma

Italy
University Hospital, Ghent

Completed

A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer

Squamous Cell Carcinoma

Belgium
University of Utah
National Cancer Institute (NCI)

Completed

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism

Venothromboembolism

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Positron Emission Tomography/Magnetic Resonance Imaging in Patients

Melanoma | Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Head and Neck Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Colon Cancer | Malignant Neoplasm

United States
Region Västerbotten
Umeå University

Recruiting

Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN) (PRODIGYN)

Cervix Cancer | Endometrial Cancer | Epithelial Ovarian Cancer

Sweden
Washington University School of Medicine
National Cancer Institute (NCI)

Recruiting

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) FDG PET/CT for Malignant Lesion Detection

Cancer

United States
National Taiwan University Hospital

Recruiting

The Brain Metabolic Change in Chronic Cancer Pain Patient: FDG PET Image Study

Cancer Pain

Taiwan
Washington University School of Medicine
Cystic Fibrosis Foundation

Completed

FDG-PET Imaging in Young Cystic Fibrosis Patients

Cystic Fibrosis

United States
Gruppo Italiano Studio Linfomi
Registro Tumori di Modena; Registro Tumori di Reggio Emilia; Registro Tumori... and other collaborators

Completed

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification

Italy
IRCCS San Raffaele

Completed

Study of Cerebral Glucose Metabolism in Neurodegenerative Diseases and Head Trauma

Neurodegenerative Diseases
King Faisal Specialist Hospital & Research Center

Completed

Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT

Lymphoma, Non-Hodgkin | Hodgkin Disease
Medanta Institute of Clinical Research

Unknown

A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.

Glioblastoma
Duke University

Recruiting

Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers

Esophageal Cancer | Vulvar Cancer | Anal Canal Cancer | Cancer of the Cervix

United States
Ankara University
Ankara Yildirim Beyazıt University; Saglik Bilimleri Universitesi; Liv Hospital...

Recruiting

Evaluation of Response by FLT PET in Mesothelioma (FLT-MM)

Chemotherapy Effect | Pleural Mesothelioma | Treatment Response

Turkey
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism (ENCEPHATAIP)

Autoimmune Encephalitis

France
University of Milano Bicocca

Recruiting

FDG-PET in the Diagnosis of Autoimmune Encephalitis (PEA)

Autoimmune Encephalitis

Italy
Centre Oscar Lambret
Ministry of Health, France

Completed

Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET (CHIMTEP)

Breast Cancer

France
University Hospital, Caen

Completed

HYPONCO - Hypoxia in Brain Tumors (HYPONCO)

Anaplastic Glioma

France
University of Oklahoma
Midwest Medical Isotopes

Terminated

Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
Jewish General Hospital

Recruiting

FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis

Vasculitis | Giant Cell Arteritis

Canada
Institute of Oncology Ljubljana
University of Ljubljana

Unknown

FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy

Correlation of iRADIOMICS and irRC With Survival

Slovenia
Centre Hospitalier Universitaire Saint Pierre

Completed

PET/CT in Extrapulmonary TB in HIV Patients: a Clinical Trial

Extrapulmonary Tuberculosis in HIV Patients
Merck Sharp & Dohme LLC

Completed

A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Alzheimer's Disease
Norwegian University of Science and Technology
University Hospital of North Norway; University of Bergen; St. Olavs Hospital

Recruiting

The EMINENCE Study - PET/MR Imaging of Head Neck Cancer (EMINENCE)

Head and Neck Neoplasms

Norway
Washington University School of Medicine

Terminated

PET/MR for Rectal Cancer Treatment Monitoring and Surveillance

Rectal Cancer | Cancer of the Rectum

United States
Jules Bordet Institute

Completed

PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome. (earlyPETmCRC)

Colorectal Cancer Metastatic | Early Response Evaluation | Fdg-PET

Belgium
Peking University

Unknown

Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms

Neuroendocrine Tumors

China
King's College Hospital NHS Trust

Recruiting

The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs)

Pheochromocytoma | Paraganglioma

United Kingdom
Abramson Cancer Center at Penn Medicine

Active, not recruiting

FDG PET/CT in Lung Cancer Staging

Non-Small Cell Lung Cancer (NSCLC)

United States
University of Zurich

Withdrawn

Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach

Adenocarcinoma | Stomach Cancer | Cancer of Esophagogastric Junction

Switzerland
Rabin Medical Center

Unknown

Evaluation of PET CT in the Management of Patients With Crohn's Disease.

Crohn's Disease

Israel
Université de Sherbrooke

Unknown

Use of FDG PET/CT to Evaluate Crohn Disease

Crohn Disease

Canada
Memorial Sloan Kettering Cancer Center

Completed

Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging

Transitional Cell Carcinoma | Bladder Cancer

United States
University of Pennsylvania

Completed

PET/CT in Psoriatic Arthritis

Psoriatic Arthritis

United States
Centre Francois Baclesse

Completed

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy (TERMATEP)

Metastasis | Non-seminomatous Germ Cell Tumors

France
Odense University Hospital

Unknown

Dual PET/CT Imaging in Lung Cancer (DILUCE)

Lung Cancer

Denmark
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer

Malignant Neoplasm of Breast TNM Staging Distant Metastasis (M) | Untreated Bone Metastases

United States
Tim Lau
McGill University

Not yet recruiting

Implementation and Evaluation of Improved Access to Medical Imaging for Geriatric Patients of The Royal Ottawa Hospital

Cognitive Impairment | Dementia | Dementia With Lewy Bodies
Jules Bordet Institute
Eli Lilly and Company

Completed

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib (MiMe-A)

Cholangiocarcinoma | Endometrial Cancer | Esophageal Adenocarcinoma | Urothelial/Bladder Cancer, Nos | Esophagus SCC

France, Belgium
Peter MacCallum Cancer Centre, Australia
Melbourne Health; Westmead Hospital; Victorian Infectious Diseases Reference...

Completed

PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia (PIPPIN)

Acute Myeloid Leukemia | Febrile Neutropenia | Acute Lymphoblastic Leukemia | Haematopoietic Stem Cell Transplant, Autologous | Haematopoietic Stem Cell Transplant, Allogeneic

Australia
National Cancer Institute (NCI)

Recruiting

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Neuroendocrine Tumors | Neuroendocrine Neoplasms | Gastroenteropancreatico Tumors

United States
Cambridge University Hospitals NHS Foundation Trust

Recruiting

Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer (NaRNIA)

Breast Cancer

United Kingdom
Odense University Hospital

Active, not recruiting

Molecular Evaluation in Metastatic Breast Cancer (MESTAR)

Metastatic Breast Cancer | Molecular Imaging

Denmark
Mayo Clinic

Completed

FDG PET/MRI Evaluation of Facet Joint Pain

Low Back Pain

United States
University of California, Los Angeles
Centers for Medicare and Medicaid Services

Withdrawn

Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II

Mild Cognitive Impairment
Stanford University

Completed

Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx

Pancreatic Cancer

United States
University of California, Los Angeles
Centers for Medicare and Medicaid Services

Completed

Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)

Dementia

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Hybrid PET/MR in the Therapy of Cervical Cancer

Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Cervix Carcinoma

United States

Search clinical trials for: FDG-PET scanning

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations